Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Materials (Basel, Switzerland)|March 28, 2024
Development of a Resveratrol Nanoformulation for the Treatment of Diabetic RetinopathyJuliana Gonzalez-Perez, A M Lopera-Echavarría, Said Arevalo-Alquichire, et al.
Ophthalmology Science|July 20, 2026
Deep Learning-Guided Retinal Vascular Morphometric Quantification in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Mouse ModelsHyungwoo Lee, Na-Kyung Ryoo, Said Arevalo-Alquichire, et al.
Ophthalmology Science|October 10, 2022
Topical Nanoemulsion of a Runt-related Transcription Factor 1 Inhibitor for the Treatment of Pathologic Ocular AngiogenesisSantiago Delgado-Tirado, Lucia Gonzalez-Buendia, Miranda An, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 22, 2026
Plasma extracellular vesicles from APOE3 Christchurch carriers display a protective phenotype in early stages of autosomal dominant Alzheimer's diseaseLina Pineda-Lopez, David Aguillon, Juan Villar-Vesga, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 10, 2025
ApoE3 Christchurch and tau interaction as a protective mechanism against Alzheimer's diseasePaula Perez-Corredor, Said Arevalo-Alquichire, Randall C Mazzarino, et al.
Scientific Reports|December 1, 2020
Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathySantiago Delgado-Tirado, Dhanesh Amarnani, Guannan Zhao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 4, 2023
APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylationClaudia Marino, Paula Perez-Corredor, Michael O'Hare, et al.
Science Translational Medicine|November 27, 2024
An mRNA-encoded dominant-negative inhibitor of transcription factor RUNX1 suppresses vitreoretinal disease in experimental modelsMichael O'Hare, William P Miller, Said Arevalo-Alquichire, et al.
Nature Medicine|May 15, 2023
Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous manFrancisco Lopera, Claudia Marino, Anita S Chandrahas, et al.
Pageof 1